Frequently Asked Questions
QDx Pathology and IMD have been brought together under the unified LabGenomics brand. This reflects the integration of both laboratories into one organization, allowing us to align our expertise in pathology and molecular diagnostics under a single name while continuing to serve our clients with the same trusted teams and services.
No immediate changes are required. You will continue working with the same teams, contacts, and processes you use today. This integration is designed to strengthen our capabilities while maintaining the service experience you rely on.
In most cases, no changes are required. Updated requisition forms will be provided as part of the rollout, but ordering workflows and processes will remain the same. Your LabGenomics representative will guide you through any updates.
LabGenomics brings together expanded diagnostic capabilities across anatomical pathology and molecular testing, including next-generation sequencing (NGS), oncology testing, flow cytometry, and PCR-based testing. This allows providers to access a broader range of services through a more integrated laboratory platform.
- You can continue contacting your existing representative or client services team. Our team is available to answer questions and ensure a smooth transition. You can reach out to our labs directly:
- Edison – Client Services Department
866-909-7284 (PATH)
info@labgusa.com - Berkeley – Customer Service Department
510-644-0951
custerv@imdpath.com - Aurora – Customer Service Department
720-859-4056
custserv@imdpath.com
No. There are no changes to service levels, turnaround times, or quality standards. Clients can expect the same reliability and responsiveness they experience today, with the added benefit of expanded capabilities.